- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04829526
Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome (FOCUS on GBS)
May 4, 2022 updated by: University Hospital, Basel, Switzerland
Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome (FOCUS on GBS)
The aim of this retrospective observational single-center cohort study is to gain a deeper understanding regarding the frequency, the clinical and electrophysiologic characteristics (e.g., the diagnostic work up), complications, treatment regimes, and their associations with specific courses of disease and outcomes in adult patients with the suspected or proven diagnosis of GBS.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Guillain Barré Syndrome (GBS) is a rare and life-threatening neurological emergency.
The aim of this retrospective study including adult GBS patients from the last 15 years treated at the University Hospital of Basel is to assess data regarding diagnostic workup, treatment, clinical course including complications and outcomes.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Raoul Sutter, Prof. Dr. med.
- Phone Number: +41 61 32 87 928
- Email: raoul.sutter@usb.ch
Study Contact Backup
- Name: Lisa Hert, Dr. med.
- Email: lisa.hert@usb.ch
Study Locations
-
-
-
Basel, Switzerland, 4031
- Recruiting
- Clinic for Intensive Care Medicine; University Hospital Basel
-
Contact:
- Lisa Hert, Dr. med.
- Email: lisa.hert@usb.ch
-
Contact:
- Raoul Sutter, Prof. Dr. med.
- Email: raoul.sutter@usb.ch
-
Principal Investigator:
- Raoul Sutter, Prof. Dr. med.
-
Sub-Investigator:
- Lisa Hert, Dr. med.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients with the suspected and with the final proven diagnosis of GBS in the years 2005-2021
Description
Inclusion Criteria:
- suspected diagnosis of GBS, who have been treated at the University Hospital of Basel from 01.01.2005-28.02.2021
Exclusion Criteria:
- Patients with documented refusal of the general consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
frequency of GBS
Time Frame: one time retrospective assessment at baseline
|
frequency of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)
|
one time retrospective assessment at baseline
|
clinical characteristics of GBS
Time Frame: one time retrospective assessment at baseline
|
clinical characteristics of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)
|
one time retrospective assessment at baseline
|
electrophysiologic characteristics of GBS
Time Frame: one time retrospective assessment at baseline
|
electrophysiologic characteristics of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)
|
one time retrospective assessment at baseline
|
complications of GBS
Time Frame: one time retrospective assessment at baseline
|
complications of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)
|
one time retrospective assessment at baseline
|
treatment regimes of GBS
Time Frame: one time retrospective assessment at baseline
|
treatment regimes of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)
|
one time retrospective assessment at baseline
|
outcomes of GBS
Time Frame: one time retrospective assessment at baseline
|
treatment regimes of GBS of all consecutive adult patients with the suspected initial diagnosis of GBS (admitted to the University Hospital Basel)
|
one time retrospective assessment at baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Raoul Sutter, Prof. Dr. med., Clinic for Intensive Care Medicine, University Hospital Basel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2021
Primary Completion (Anticipated)
December 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
March 29, 2021
First Submitted That Met QC Criteria
April 1, 2021
First Posted (Actual)
April 2, 2021
Study Record Updates
Last Update Posted (Actual)
May 5, 2022
Last Update Submitted That Met QC Criteria
May 4, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-00402; ko21Sutter
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Guillain-Barre Syndrome (GBS)
-
Hansa Biopharma ABCompletedGuillain-Barré Syndrome (GBS)France, Netherlands, United Kingdom
-
Junwei HaoCompleted
-
Mansoura University HospitalUnknownGuillain Barre SyndromeEgypt
-
Ning Wang, MD., PhD.Recruiting
-
Mansoura University Children HospitalCompletedGuillain Barre SyndromeEgypt
-
University of UlmDiaMed GmbHRecruiting
-
Hoffmann-La RocheChugai Pharmaceutical Co., Ltd. (Sponsor in Taiwan and Japan)Withdrawn
-
Annexon, Inc.International Centre for Diarrhoeal Disease Research, Bangladesh; ResearchPoint...CompletedGuillain-Barré SyndromeDenmark, Bangladesh
-
International Centre for Diarrhoeal Disease Research...Erasmus Medical Center; GBS-CIDP Foundation International; National Institute...CompletedGuillain-Barré SyndromeBangladesh
-
Nihon Pharmaceutical Co., LtdCompletedGuillain-Barré SyndromeJapan
Clinical Trials on data collection
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
University Hospital, Basel, SwitzerlandRecruitingInfections With CPBSwitzerland
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Hospices Civils de LyonCompleted
-
Women and Infants Hospital of Rhode IslandTerminated